DNA RNA and Cells

27 May 2017 Kite Receives U.S. Food and Drug Administration Priority Review for Axicabtagene Ciloleucel
26 May 2017 Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting NY-ESO in Combination with KEYTRUDA® (pembrolizumab) in Multiple Myeloma
26 May 2017 Akcea Announces Publication in The New England Journal of Medicine of Data with AKCEA-ANGPTL3-L Rx Showing Favorable Cardiometabolic Effects
23 May 2017 ORYX reports positive clinical evidence with oncolytic virus ParvOryx in combination with immuno-oncology drugs
22 May 2017 ViaCyte Receives IND Allowance from FDA and Clearance from Health Canada to Commence International Clinical Trial of PEC-Direct Cell Therapy for High-Risk Type 1 Diabetes
18 May 2017 Oncolytics Biotech® Announces ASCO Abstracts and Preliminary Data for Studies in Pancreatic and Prostate Cancers
17 May 2017 Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Cell Treatment in Frailty Patients
16 May 2017 Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors
15 May 2017 Selecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
15 May 2017 ToolGen, Inc. Announces Poster Presentation on Genome Editing of Human T Cells at 2017 American Society for Gene and Cell Therapy (ASGCT) Annual Meeting
15 May 2017 Tactiva Therapeutics Presents Positive Data on Novel Dual CD4/CD8 T Cell Receptor in Preclinical Models of Cancer
15 May 2017 Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac
15 May 2017 Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the American Society of Gene & Cell Therapy
15 May 2017 MOLOGEN AG: Recruitment goal achieved for the pivotal IMPALA study with lefitolimod in colorectal cancer patients
15 May 2017 Isarna Presents Positive Clinical Data for ISTH0036 in Advanced Glaucoma and Preclinical Data Supportive of AMD/DME Potential at ARVO 2017 Annual Conference
15 May 2017 Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen (IONIS-TTR Rx) Meets Both Primary Endpoints
14 May 2017 Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas
14 May 2017 Intellia Therapeutics Announces Progress with CRISPR/Cas9 at the American Society of Gene & Cell Therapy Annual Meeting
13 May 2017 Capricor Therapeutics Provides Update on ALLSTAR Trial
13 May 2017 First study of Oncolytic HSV-1 in children and young adults with cancer indicates safety, tolerability
11 May 2017 VBL Therapeutics Presents Data on VB-111 in Combination with Checkpoint Inhibitor at the 20th Annual ASGCT Meeting
11 May 2017 AGTC Presents New Data on its AAV-Based Gene Therapies for the Treatment of Achromatopsia and X-Linked Retinitis Pigmentosa at the American Society of Gene and Cell Therapy 20th Annual Meeting
11 May 2017 Editas Medicine Announces Pre-Clinical Data for Program to Treat Sickle Cell Disease and Beta-Thalassemia
11 May 2017 DNAtrix Oncolytic Myxoma Virus Eliminates Treatment-Resistant Cancer
11 May 2017 Dimension Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top